Stay updated on Pembrolizumab Combo in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision: v3.5.0 is now displayed, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T08:56:25.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Added revision note for v3.4.3 and removed the previous v3.4.2 revision.
    Difference
    0.1%
    Check dated 2026-03-06T19:04:29.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Fallopian tube cancer was added to the Conditions section. A new page revision tag shows Revision: v3.4.2 (replacing v3.4.1).
    Difference
    0.1%
    Check dated 2026-02-13T07:44:00.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page now lists Primary Peritoneal Carcinoma and adds a resource link to the Genetic and Rare Diseases Information Center. The site revision updated from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-05T14:20:47.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Glossary toggle text added; metadata labels updated (Last Update Submitted that Met QC Criteria, No FEAR Act data) and Revision: v3.4.0, replacing the previous lowercase variants and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-29T07:32:38.000Z thumbnail image
  9. Check
    75 days ago
    Change Detected
    Summary
    The Study Record Dates section changes from 'Last Update Posted (Estimated)' to 'Last Update Posted'. This update is limited to a labeling change and does not modify any study data or core content.
    Difference
    0.1%
    Check dated 2026-01-22T05:22:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page.